首页> 外文期刊>Scientia pharmaceutica >In Silico Study to Develop a Lectin-Like Protein from Mushroom Agaricus bisporus for Pharmaceutical Application
【24h】

In Silico Study to Develop a Lectin-Like Protein from Mushroom Agaricus bisporus for Pharmaceutical Application

机译:在计算机模拟研究中从蘑菇双孢蘑菇中开发类似于凝集素的蛋白质,用于药物应用

获取原文
           

摘要

A lectin-like protein of unknown function designated as LSMT was recently discovered in the edible mushroom Agaricus bisporus. The protein shares high structural similarity to HA-33 from Clostridium botulinum (HA33) and Ricin-B-like lectin from the mushroom Clitocybe nebularis (CNL), which have been developed as drug carrier and anti-cancer, respectively. These homologous proteins display the ability to penetrate the intestinal epithelial cell monolayer, and are beneficial for oral administration. As the characteristics of LSMT are unknown, a structural study in silico was performed to assess its potential pharmaceutical application. The study suggested potential binding to target ligands such as HA-33 and CNL although the nature, specificity, capacity, mode, and strength may differ. Further molecular docking experiments suggest that interactions between the LSMT and tested ligands may take place. This finding indicates the possible use of the LSMT protein, initiating new research on its use for pharmaceutical purposes.
机译:最近在食用蘑菇双孢蘑菇中发现了一种功能未知的凝集素样蛋白,称为LSMT。该蛋白与肉毒梭菌(HA33)的HA-33和蘑菇Clitocybe nebularis(CNL)的Ricin-B样凝集素具有很高的结构相似性,它们分别被开发为药物载体和抗癌药。这些同源蛋白表现出穿透肠上皮细胞单层的能力,并且对于口服给药是有益的。由于LSMT的特性未知,因此在计算机上进行了结构研究以评估其潜在的药物应用。这项研究表明,尽管其性质,特异性,容量,模式和强度可能不同,但可能与目标配体(例如HA-33和CNL)结合。进一步的分子对接实验表明,LSMT和测试的配体之间可能发生相互作用。该发现表明了LSMT蛋白的可能用途,开始对其用于药物用途的新研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号